INFUSYSTEM HOLDINGS, INC Sales-type Lease, Lease Receivable
INFUSYSTEM HOLDINGS, INC (INFU) had Sales-type Lease, Lease Receivable of $1.69 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:SalesTypeLeaseLeaseReceivable · last filed 2026-08-04
- 2026-06-30: Sales-type Lease, Lease Receivable $1.69M.
- 2026-03-31: Sales-type Lease, Lease Receivable $1.78M.
- 2025-12-31: Sales-type Lease, Lease Receivable $1.91M.
- 2025-09-30: Sales-type Lease, Lease Receivable $1.15M.
| Period end | Sales-type Lease, Lease Receivable |
|---|---|
| 2026-06-30 | $1.69M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.78M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.91M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $1.15M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $1.42M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.68M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.93M 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.10M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $2.33M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $2.53M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.58M 10-K · filed 2025-03-11 |
| 2022-12-31 | $45.00K 10-K · filed 2024-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |